actinic keratosis

MauiDerm 2014 kicks off with therapeutic updates, industry advancesThe MauiDerm 2014 meeting kicked off Sunday with a Hawaiian blessing led by the conference's organizer, George Martin, M.D., Dermatology and Laser Center of Maui, Kihei, Hawaii.
Sandoz to offer generic SolarazeSandoz has announced the U.S. launch of an authorized generic version of PharmaDerm’s Solaraze Gel (diclofenac 3% gel), which generated $92 million in 2012.
Combination therapies evolve to address countless dermatologic conditionsDermatologists are using an evolving collection of combination therapies designed to address different aspects of disease, monotherapy limitations and failures, as well as enhance treatment.
Reformulated drugs for actinic keratosis address issues with field therapy
Reformulated drugs for actinic keratosis address issues with field therapyNew topical agents such as ingenol mebutate (Picato, Leo Pharma), reformulations of standing local treatments as well as combination therapies are not only proving to be very useful in the clearance of actinic keratosis (AK), but they also help address the common issues regarding field therapy.
Radiation therapy plays rare but useful role in AK managementDespite the number of currently available options for the treatment of actinic keratoses (AKs), dermatologists are still challenged by the occasional patient with widespread lesions refractory to multiple modalities.